Rhoen Klinikum AG
XETRA:RHK
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
9.55
13.3
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one RHK stock under the Base Case scenario is 19.74 EUR. Compared to the current market price of 12.5 EUR, Rhoen Klinikum AG is Undervalued by 37%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Rhoen Klinikum AG
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for RHK cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Rhoen Klinikum AG
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Rhoen Klinikum AG
Balance Sheet Decomposition
Rhoen Klinikum AG
Current Assets | 885m |
Cash & Short-Term Investments | 589.7m |
Receivables | 240.5m |
Other Current Assets | 54.8m |
Non-Current Assets | 956.5m |
Long-Term Investments | 13.4m |
PP&E | 769.1m |
Intangibles | 174m |
Current Liabilities | 376.9m |
Accounts Payable | 65.9m |
Other Current Liabilities | 311m |
Non-Current Liabilities | 183.2m |
Long-Term Debt | 141.9m |
Other Non-Current Liabilities | 41.4m |
Earnings Waterfall
Rhoen Klinikum AG
Revenue
|
1.5B
EUR
|
Cost of Revenue
|
-530.9m
EUR
|
Gross Profit
|
1B
EUR
|
Operating Expenses
|
-970m
EUR
|
Operating Income
|
45.2m
EUR
|
Other Expenses
|
-330k
EUR
|
Net Income
|
44.9m
EUR
|
Free Cash Flow Analysis
Rhoen Klinikum AG
EUR | |
Free Cash Flow | EUR |
RHK Profitability Score
Profitability Due Diligence
Rhoen Klinikum AG's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Rhoen Klinikum AG's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
RHK Solvency Score
Solvency Due Diligence
Rhoen Klinikum AG's solvency score is 76/100. The higher the solvency score, the more solvent the company is.
Score
Rhoen Klinikum AG's solvency score is 76/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RHK Price Targets Summary
Rhoen Klinikum AG
According to Wall Street analysts, the average 1-year price target for RHK is 13.77 EUR with a low forecast of 12.12 EUR and a high forecast of 16.8 EUR.
Dividends
Current shareholder yield for RHK is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Rhön-Klinikum AG engages in the provision of healthcare services. The company is headquartered in Bad Neustadt An Der Saale, Bayern and currently employs 18,227 full-time employees. The company operates acute hospitals, medical care centers and rehabilitation hospitals across Germany: six clinics on Campus Bad Neustadt, including the Cardiovascular Clinic, the Frankenklinik for the Rehabilitation of Cardiovascular Patients, the Clinic for Hand Surgery, the Neurological Clinic, the Psychosomatic Clinic and the Saaletalklinik with two additional addiction therapy facilities; Klinikum Frankfurt (Oder) comprises clinics, psychiatric outpatient institutions and day clinics; University Hospital Giessen and Marburg (UKGM) offers medical services, modern diagnostics and comprehensive therapy in various areas, including ophthalmology, trauma surgery and dentistry, and Zentralklinik Bad Berka provides health care services to patients with thoracic, pulmonary and vascular diseases, tumors, neurological conditions, and diseases of the spinal column, joints and heart, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one RHK stock under the Base Case scenario is 19.74 EUR.
Compared to the current market price of 12.5 EUR, Rhoen Klinikum AG is Undervalued by 37%.